cover image: Post-COVID-19 Condition Treatment and Management Rapid Scoping Review

20.500.12592/cfxpt2c

Post-COVID-19 Condition Treatment and Management Rapid Scoping Review

12 Dec 2023

(treatment* or therap* or management or managing or drug? or medication? or pharmacolog* or pharmaceutic* or non-drug? or nonpharmacolog* or non-pharmacolog* or biologic or biologics or diet* or supplement* or vitamin* or treat or treated or treating or placebo* or off-label*).ti,kf. [...] (treatment* or therap* or management or managing or drug? or medication? or pharmacolog* or pharmaceutic* or non-drug? or nonpharmacolog* or non-pharmacolog* or biologic or biologics or diet* or supplement* or vitamin* or treat or treated or treating or placebo* or off-label*).ab. [...] (treatment* or therap* or management or managing or drug? or medication? or pharmacolog* or pharmaceutic* or non-drug? or nonpharmacolog* or non-pharmacolog* or biologic or biologics or diet* or supplement* or vitamin* or treat or treated or treating or placebo* or off-label*).ti,kf. [...] (treatment* or therap* or management or managing or drug? or medication? or pharmacolog* or pharmaceutic* or non-drug? or nonpharmacolog* or non-pharmacolog* or biologic or biologics or diet* or supplement* or vitamin* or treat or treated or treating or placebo* or off-label*).ab. [...] (Ampligen* or AMP511 or AMP-511 or ((AT1011 or AT-1011) and Meters*) or celecoxib* or colchichine* or CoQ10 or famotidine* or fluvoxamine* or forlumab* or TZLS401 or TZLS-401 or ((IMC2 or IMC-2) and Vioros*) or larazotide* or AT1001 or metformin* or Fortamet* or Glucophage* or palmitoylethanolamide* or rivaroxaban* or (sodium gluconate and (spray* or nasal* or intranasal*)) or valacyclovir* or TNX.

Authors

CADTH

Pages
14
Published in
Canada